Bioinformatic analysis and experimental validation implicate STAT2-mediated angiogenic responses in rosacea pathogenesis
- PMID: 39945902
- DOI: 10.1007/s00403-025-03915-7
Bioinformatic analysis and experimental validation implicate STAT2-mediated angiogenic responses in rosacea pathogenesis
Abstract
Rosacea is a chronic skin condition characterized by facial erythema, flushing, and telangiectasia. Abnormalities in the vascular responses are associated with the development of rosacea. Our analysis of the GSE65914 dataset revealed differential expression of angiogenesis-related genes in rosacea lesions classified rosacea samples with distinct angiogenic molecular patterns. Further investigation of immune infiltration characteristics across angiogenic patterns identified unique immune signatures associated with VEGFAhigh MMP9low and VEGFAlow MMP9high subtypes. Moreover, STAT2 proteins were higher in the VEGFAhigh MMP9low pattern group. Increased expression of STAT2 was confirmed in rosacea patients and in the mice model of rosacea induced by LL37. Knockdown of STAT2 suppressed the tube formation ability of human umbilical vein endothelial cells, which implicated STAT2 participated in regulating angiogenic responses. In conclusion, our study characterized rosacea subtypes by distinct angiogenic molecular patterns and found that STAT2 may play a critical role in the regulation of angiogenic responses in rosacea. These insights may provide a promising target of rosacea therapies.
Keywords: Angiogenesis; HUVEC; Rosacea; STAT2.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Impaired Angiogenesis and Th1/Th17 Polarization: A Possible Explanation for the Decreased Incidence of Rosacea in the Aged.Immun Inflamm Dis. 2024 Dec;12(12):e70108. doi: 10.1002/iid3.70108. Immun Inflamm Dis. 2024. PMID: 39692542 Free PMC article.
-
Recombinant erythroid differentiation regulator 1 inhibits both inflammation and angiogenesis in a mouse model of rosacea.Exp Dermatol. 2015 Sep;24(9):680-5. doi: 10.1111/exd.12745. Epub 2015 Jul 14. Exp Dermatol. 2015. PMID: 25940661
-
Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.J Investig Dermatol Symp Proc. 2011 Dec;15(1):53-62. doi: 10.1038/jidsymp.2011.6. J Investig Dermatol Symp Proc. 2011. PMID: 22076328 Free PMC article.
-
Signaling pathways and targeted therapy for rosacea.Front Immunol. 2024 Sep 16;15:1367994. doi: 10.3389/fimmu.2024.1367994. eCollection 2024. Front Immunol. 2024. PMID: 39351216 Free PMC article. Review.
-
The molecular pathology of rosacea.J Dermatol Sci. 2009 Aug;55(2):77-81. doi: 10.1016/j.jdermsci.2009.04.007. Epub 2009 May 29. J Dermatol Sci. 2009. PMID: 19481425 Free PMC article. Review.
Cited by
-
Complete Resolution of Granulomatous Rosacea With Topical Ruxolitinib.Cureus. 2025 Apr 17;17(4):e82457. doi: 10.7759/cureus.82457. eCollection 2025 Apr. Cureus. 2025. PMID: 40385835 Free PMC article.
References
-
- Chen C et al (2023) Exploring the Pathogenesis and mechanism-targeted treatments of Rosacea: previous understanding and updates. Biomedicines, 11(8)
MeSH terms
Substances
Grants and funding
- 82404134/National Natural Science Foundation of China
- JCYJ20220530160207016/Shenzhen Science and Technology Program
- JCYJ20240813162500001/Shenzhen Science and Technology Program
- SZSM202311029/Sanming Project of Medicine in Shenzen Municipality
- SZXK040/Shenzhen Key Medical Discipline Construction Fund
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous